Naviscan, an organ-specific molecular imaging company backed by Mayo Medical Ventures, a corporate venturing unit of Mayo Clinic, has raised $1m as part of a $3m equity round.
The company previously secured $830k of a $2.2m debt, warrants and securities offering, according to an October 2011 filing.
In 2007, the company received a $15m Series C round from investors including venture capital firms Mayo Medical Ventures, QuestMark Partners, Sanderling Ventures and Walker Ventures.